glp 1 receptor agonists effects on cardiovascular risk reduction Results of outcomes trials comparing GLP-1 Impact of GLP-1 receptor agonists
Description
Retrieved from ASMBS Website.
Objective To investigate whether the use of GLP-1 RAs in patients with T2D is associated with the development of DR, NAION, or DR complications
[DOI] [PMC free article] [PubMed] [Google Scholar] 5.Luo J., Feldman R., Kim K.C., et al
You might also find the guide on peptides and semaglutide useful for understanding the broader classification context
A comprehensive review of GLP-1 and aerobic training in cardiovascular disease management
